Exane Derivatives Boston Scientific Corp Transaction History
Exane Derivatives
- $157 Million
- Q2 2022
A detailed history of Exane Derivatives transactions in Boston Scientific Corp stock. As of the latest transaction made, Exane Derivatives holds 43,067 shares of BSX stock, worth $3.51 Million. This represents 1.03% of its overall portfolio holdings.
Number of Shares
43,067
Previous 45,926
6.23%
Holding current value
$3.51 Million
Previous $2.03 Million
21.09%
% of portfolio
1.03%
Previous 0.63%
Shares
20 transactions
Others Institutions Holding BSX
# of Institutions
1,448Shares Held
1.21BCall Options Held
8.14MPut Options Held
8.3M-
Vanguard Group Inc Valley Forge, PA130MShares$10.6 Billion0.2% of portfolio
-
Black Rock Inc. New York, NY126MShares$10.3 Billion0.22% of portfolio
-
State Street Corp Boston, MA61.5MShares$5.01 Billion0.21% of portfolio
-
Primecap Management CO Pasadena, CA38MShares$3.1 Billion2.15% of portfolio
-
Wellington Management Group LLP Boston, MA32.1MShares$2.62 Billion0.45% of portfolio
About BOSTON SCIENTIFIC CORP
- Ticker BSX
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,431,609,984
- Market Cap $117B
- Description
- Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...